Lepercq De Neuflize Asset Management LLC Lava Therapeutics Nv Transaction History
Lepercq De Neuflize Asset Management LLC
- $103 Billion
- Q1 2025
A detailed history of Lepercq De Neuflize Asset Management LLC transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Lepercq De Neuflize Asset Management LLC holds 23,000 shares of LVTX stock, worth $28,520. This represents 0.03% of its overall portfolio holdings.
Number of Shares
23,000Holding current value
$28,520% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding LVTX
# of Institutions
22Shares Held
4.93MCall Options Held
50.2KPut Options Held
200-
Redmile Group, LLC San Francisco, CA2.07MShares$2.57 Million0.28% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.96MShares$2.43 Million2.02% of portfolio
-
Bruce & Co., Inc. Chicago, IL522KShares$647,1230.28% of portfolio
-
Pathway Financial Advisors LLC103KShares$127,1000.03% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA65KShares$80,6000.0% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $32M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...